In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.

Ex Input:
SECTION 1. DEVELOPMENT OF BEST PRACTICES FOR THE USE OF PRESCRIPTION
OPIOIDS.

(a) Definitions.--In this section--
(1) the term ''Secretary'' means the Secretary of Health
and Human Services; and
(2) the term ''task force'' means the Pain Management Best
Practices Inter-Agency Task Force convened under subsection
(b).
(b) Inter-Agency Task Force.--Not later than December 14, 2018, the
Secretary, in cooperation with the Secretary of Veterans Affairs, the
Secretary of Defense, and the Administrator of the Drug Enforcement
Administration, shall convene a Pain Management Best Practices Inter-
Agency Task Force to review, modify, and update, as appropriate, best
practices for pain management (including chronic and acute pain) and
prescribing pain medication.
(c) Membership.--The task force shall be comprised of--
(1) representatives of--
(A) the Department of Health and Human Services;
(B) the Department of Veterans Affairs;
(C) the Food and Drug Administration;
(D) the Department of Defense;
(E) the Drug Enforcement Administration;
(F) the Centers for Disease Control and Prevention;
(G) the Health Resources and Services
Administration;
(H) the Indian Health Service;
(I) the National Academy of Medicine;
(J) the National Institutes of Health;
(K) the Office of National Drug Control Policy;
(L) the Substance Abuse and Mental Health Services
Administration; and
(M) the Office of Women's Health;
(2) State medical boards;
(3) subject to subsection (e), physicians, dentists, and
nonphysician prescribers;
(4) hospitals;
(5) subject to subsection (e), pharmacists and pharmacies;
(6) first responders;
(7) experts in the fields of pain research and addiction
research;
(8) experts in the fields of adolescent and young adult
addiction research;
(9) representatives of--
(A) pain management professional organizations;
(B) the mental health treatment community;
(C) the addiction treatment and recovery community;
(D) pain advocacy groups;
(E) veteran service organizations; and
(F) groups with expertise on overdose reversal;
(10) a person in recovery from addiction to medication for
chronic pain;
(11) a person in recovery from addiction to medication for
chronic pain, whose addiction began in adolescence or young
adulthood;
(12) a person with chronic pain;
(13) an expert on active duty military, armed forces
personnel, and veteran health and prescription opioid
addiction;
(14) an expert in the field of minority health; and
(15) other stakeholders, as the Secretary determines
appropriate.
(d) Condition on Participation on Task Force.--An individual
representing a profession or entity described in paragraph (3) or (5)
of subsection (c) may not serve as a member of the task force unless
such individual--
(1) is currently licensed in a State in which such
individual is practicing (as defined by such State) such
profession (or, in the case of an individual representing an
entity, a State in which the entity is engaged in business);
and
(2) is currently practicing (as defined by such State) such
profession (or, in the case of an individual representing an
entity, the entity is in operation).
(e) Duties.--The task force shall--
(1) not later than 180 days after the date on which the
task force is convened under subsection (b), review, modify,
and update, as appropriate, best practices for pain management
(including chronic and acute pain) and prescribing pain
medication, taking into consideration--
(A) existing pain management research;
(B) research on trends in areas and communities in
which the prescription opioid abuse rate and fatality
rate exceed the national average prescription opioid
abuse rate and fatality rate;
(C) recommendations from relevant conferences and
existing relevant evidence-based guidelines;
(D) ongoing efforts at the State and local levels
and by medical professional organizations to develop
improved pain management strategies, including
consideration of differences within and between classes
of opioids, the availability of opioids with abuse
deterrent technology, and pharmacological,
nonpharmacological, medical device alternatives to
opioids to reduce opioid monotherapy in appropriate
cases and the coordination of information collected
from State prescription drug monitoring programs for
the purpose of preventing the diversion of pain
medication;
(E) ongoing efforts at the Federal, State, and
local levels to examine the potential benefits of
electronic prescribing of opioids, including any public
comments collected in the course of those efforts;
(F) the management of high-risk populations, other
than populations who suffer pain, who--
(i) may use or be prescribed
benzodiazepines, alcohol, and diverted opioids;
or
(ii) receive opioids in the course of
medical care;
(G) the distinct needs of adolescents and young
adults with respect to pain management, pain
medication, substance use disorder, and medication-
assisted treatment;
(H) the 2016 Guideline for Prescribing Opioids for
Chronic Pain issued by the Centers for Disease Control
and Prevention;
(I) the practice of co-prescribing naloxone for
both pain patients receiving chronic opioid therapy and
patients being treated for opioid use disorders;
(J) research that has been, or is being, conducted
or supported by the Federal Government on prevention
of, treatment for, and recovery from substance use by
and substance use disorders among adolescents and young
adults relative to any unique circumstances (including
social and biological circumstances) of adolescents and
young adults that may make adolescent-specific and
young adult-specific treatment protocols necessary,
including any effects that substance use and substance
use disorders may have on brain development and the
implications for treatment and recovery;
(K) Federal non-research programs and activities
that address prevention of, treatment for, and recovery
from substance use by and substance use disorders among
adolescents and young adults, including an assessment
of the effectiveness of such programs and activities
in--
(i) preventing substance use by and
substance use disorders among adolescents and
young adults;
(ii) treating such adolescents and young
adults in a way that accounts for any unique
circumstances faced by adolescents and young
adults; and
(iii) supporting long-term recovery among
adolescents and young adults; and
(L) gaps that have been identified by Federal
officials and experts in Federal efforts relating to
prevention of, treatment for, and recovery from
substance use by and substance use disorders among
adolescents and young adults, including gaps in
research, data collection, and measures to evaluate the
effectiveness of Federal efforts, and the reasons for
such gaps;
(2) solicit and take into consideration public comment on
the practices developed under paragraph (1), amending such best
practices if appropriate;
(3) develop a strategy for disseminating information about
the best practices developed under paragraphs (1) and (2) to
prescribers, pharmacists, State medical boards, educational
institutions that educate prescribers and pharmacists, and
other parties, as the Secretary determines appropriate;
(4) review, modify, and update best practices for pain
management and prescribing pain medication, specifically as it
pertains to physician education and consumer education; and
(5) examine and identify--
(A) the extent of the need for the development of
new pharmacological, nonpharmacological, and medical
device alternatives to opioids;
(B) the current status of research efforts to
develop such alternatives; and
(C) the pharmacological, nonpharmacological, and
medical device alternatives to opioids that are
currently available that could be better utilized.
(f) Consideration of Study Results.--In reviewing, modifying, and
updating, best practices for pain management and prescribing pain
medication, the task force shall take into consideration existing
private sector, State, and local government efforts related to pain
management and prescribing pain medication.
(g) Limitation.--The task force shall not have rulemaking
authority.
(h) Report.--Not later than 270 days after the date on which the
task force is convened under subsection (b), the task force shall
submit to Congress a report that includes--
(1) the strategy for disseminating best practices for pain
management (including chronic and acute pain) and prescribing
pain medication, as developed under subsection (e);
(2) the results of a feasibility study on linking the best
practices described in paragraph (1) to receiving and renewing
registrations under section 303(f) of the Controlled Substances
Act (21 U.S.C. 823(f));
(3) recommendations for effectively applying the best
practices described in paragraph (1) to improve prescribing
practices at medical facilities, including medical facilities
of the Veterans Health Administration and Indian Health
Service;
(4) the modified and updated best practices described in
subsection (e)(4); and
(5) the results of the examination and identification
conducted pursuant to subsection (e)(4), and recommendations
regarding--
(A) the development of new pharmacological,
nonpharmacological, and medical device alternatives to
opioids; and
(B) the improved utilization of pharmacological,
nonpharmacological, and medical device alternatives to
opioids that are currently available.

Passed the House of Representatives May 11, 2016.

Attest:

KAREN L. HAAS,

Clerk.

Ex Output:
(Sec. 1) This bill requires the Department of Health and Human Services to convene a Pain Management Best Practices Inter-Agency Task Force to: (1) review, modify, and update best practices for pain management and prescribing pain medication; and (2) examine and identify the need for, development of, and availability of medical alternatives to opioids (drugs with effects similar to opium, such as certain pain medications). The task force must submit a report that includes: (1) the modified and updated best practices; (2) a strategy for disseminating the best practices; (3) the feasibility of linking the best practices to Drug Enforcement Administration registration of manufacturers, distributors, and dispensers of controlled substances; (4) recommendations for effectively applying the best practices at medical facilities; and (5) recommendations regarding medical alternatives to opioids.

Ex Input:
SECTION 1. SHORT TITLE.

This Act may be cited as the ''Access to Frontline Health Care Act
of 2011''.

SEC. 2. FRONTLINE PROVIDERS LOAN REPAYMENT PROGRAM.

Part D of title III of the Public Health Service Act (42 U.S.C.
254b et seq.) is amended--
(1) by redesignating the second subpart XI (as added by
section 10333 of Public Law 111-148) as subpart XII;
(2) by redesignating the second section 340H (as added by
such section 10333) as section 340I; and
(3) by adding at the end the following:

''Subpart XIII--Frontline Health Care Services

''SEC. 340J. FRONTLINE PROVIDERS LOAN REPAYMENT PROGRAM.

''(a) In General.--The Secretary shall establish and carry out a
Frontline Providers Loan Repayment Program (in this section referred to
as the 'Loan Repayment Program') under which, pursuant to contracts in
accordance with this section--
''(1) the Secretary agrees to make student loan repayments;
and
''(2) the individual agrees to serve as a health
professional for a period of full-time service of not less than
2 years at a health care facility serving a frontline care
scarcity area.
''(b) Eligibility.--To be eligible to participate in the Loan
Repayment Program, an individual must--
''(1) submit an application to participate in the Loan
Repayment Program in such form and manner and at such time as
specified by the Secretary; and
''(2) sign and submit to the Secretary, at the time of
submittal of such application, a written contract (described in
subsection (d)).
''(c) Participation in Program.--
''(1) In general.--An individual becomes a participant in
the Loan Repayment Program only upon the approval of the
Secretary of the individual's application submitted under
subsection (b)(1) and the Secretary's acceptance of the
contract submitted by the individual under subsection (b)(2).
''(2) Preference.--In awarding contracts under this
section, the Secretary shall give preference to applicants who
have undertaken training or coursework in interdisciplinary
studies.
''(3) Recruitment for interdisciplinary programs.--The
Secretary shall--
''(A) determine the frontline care scarcity areas
in which to place contract recipients under this
section; and
''(B) in making such determination, give preference
to areas with a demonstrated program of
interdisciplinary health care, or with demonstrated
plans to initiate interdisciplinary approaches to
community health care.
''(4) Notice.--The Secretary shall provide written notice
to an individual promptly upon the Secretary's approving, under
paragraph (1), of the individual's participation in the Loan
Repayment Program.
''(d) Contract.--The contract described in this subsection is a
written contract between the Secretary and an individual that
contains--
''(1) an agreement that--
''(A) the Secretary agrees to provide the
individual with student loan repayment (described in
subsection (e)) for a period of time as determined by
the Secretary, to pay off debts incurred during the
course of the study or program described in subsection
(g)(2)(B); and
''(B) the individual agrees--
''(i) to accept provision of such a student
loan repayment to the individual; and
''(ii) to provide frontline care services
for a period of full-time service of not less
than 2 years at a health care facility serving
a frontline care scarcity area;
''(2) a provision that any financial obligation of the
United States arising out of a contract entered into under this
section and any obligation of the individual which is
conditioned thereon, is contingent upon funds being
appropriated for student loan repayment under this section;
''(3) a statement of the damages to which the United States
is entitled, under subsection (f), for the individual's breach
of the contract; and
''(4) such other statements as the Secretary deems
appropriate of the rights and liabilities of the Secretary and
of the individual, not inconsistent with the provisions of this
section.
''(e) Student Loan Repayment.--
''(1) Amount.--The amount of an annual student loan
repayment under this section on behalf of an individual shall
be determined by the Secretary, and shall take into
consideration the need to pay a sufficient amount to enable
recruiting of health care providers into the loan repayment
program under this section.
''(2) Payments directly to loan provider.--The Secretary
may contract with an individual's loan provider, for the
payment to the loan provider, on behalf of the individual, of
the amounts of a student loan repayment described in paragraph
(1).
''(f) Breach of Contract.--If an individual breaches a written
contract under this section by failing to begin such individual's
service obligation, or to complete such service obligation, the United
States shall be entitled to recover from the individual an amount that
is equal to the sum of--
''(1) the total amount which has been paid to the
individual, or on behalf of the individual, under the contract;
and
''(2) any amount of interest, as determined by the
Secretary.
''(g) Definitions.--In this section:
''(1) The term 'frontline care scarcity area' means an
area, population group, or facility that--
''(A) is designated as a health professional
shortage area under section 332; or
''(B) is designated by the State in which the area
is located as having a shortage of frontline care
services.
''(2) The term 'frontline care services' means health care
services--
''(A) in the field of general surgery, optometry,
ophthalmology, chiropractic, physical therapy,
audiology, speech language pathology, pharmacies,
public health, podiatric medicine, dietetics,
occupational therapy, general pediatrics, respiratory
therapy, medical technology, otolaryngology, or
radiologic technology; and
''(B) provided by a general surgeon, optometrist,
ophthalmologist, chiropractor, physical therapist,
audiologist, speech language pathologist, pharmacist,
public health professional, podiatric physician,
registered dietician, occupational therapist,
pediatrician, respiratory therapist, medical
technologist, otolaryngologist, or radiologic
technologist who has completed an appropriate course of
study or program, offered by an accredited institution
of higher education in the United States.
''(h) Implementation.--The Secretary shall begin implementation of
the loan repayment program under this section within 180 days of the
date of the enactment of this section.''.

Ex Output:
Access to Frontline Health Care Act of 2011 - Amends the Public Health Service Act to direct the Secretary of Health and Human Services (HHS) to establish and carry out a Frontline Providers Loan Repayment Program under which the Secretary agrees to make student loan repayments in exchange for a health professional providing frontline care services for two years in a frontline care scarcity area. Defines "frontline care services" as health care services in the fields of general surgery, optometry, ophthalmology, chiropractic, physical therapy, audiology, speech language pathology, pharmacies, public health, podiatric medicine, dietetics, occupational therapy, general pediatrics, respiratory therapy, medical technology, otolaryngology, or radiologic technology.

Ex Input:
SECTION 1. SHORT TITLE.

This Act may be cited as the ''Eliminating Disparities in Breast
Cancer Treatment Act of 2008''.

SEC. 2. FINDINGS.

Congress finds the following:
(1) Delays in receiving care after breast cancer diagnosis
are reported to be greater for African-American women than
white women.
(2) Recent studies indicate that African-American women
with breast cancer are less likely to receive standard therapy
than white women.
(3) African-American and Hispanic patients are
significantly more likely than white patients to be diagnosed
at a more advanced stage of breast cancer.
(4) Investigators found that regardless of insurance
status, African-American women are 1.9 times more likely to be
diagnosed with an advanced stage of breast cancer than white
women and Hispanic women are 1.4 times more likely to be
diagnosed with an advanced stage of breast cancer than white
women.
(5) African-American women are ten percent more likely not
to receive tests to determine if breast cancer has spread to
axillary (underarm) lymph nodes. Studies show that health
insurance status, race, income, and educational background are
directly linked to irregularity in administering this vital
screening.
(6) According to American Cancer Society researchers,
substantial disparities remain or persist regarding cancer
diagnosis and treatment.

SEC. 3. PURPOSE.

The purpose of this Act is to promote the implementation of
standardized health care practices for breast cancer treatment under
the Medicare program to eliminate disparities in the provision of care
to such patients based on race, level of education, income, and health
insurance status of such patients.

SEC. 4. CONSENSUS-BASED BREAST CANCER TREATMENT PERFORMANCE MEASURES
SYSTEM UNDER MEDICARE.

Title XVIII of the Social Security Act is amended by adding at the
end the following new section:

''SEC. 1898. BREAST CANCER TREATMENT PERFORMANCE MEASURES SYSTEM.

''(a) In General.--Not later than October 1, 2009, the Secretary
shall establish, in accordance with the provisions of this section, a
6-year breast cancer treatment quality performance system (in this
section referred to as the 'system') to--
''(1) assess and publicly disclose, through the use of
quality measures, the quality of care provided for the
treatment of breast cancer by specified health care providers;
and
''(2) beginning October 1, 2012, base payment under this
title to such providers for such treatment on the performance
of such providers based on such measures.
''(b) Specified Health Care Providers.--
''(1) In general.--The Secretary shall specify classes of
providers of services and suppliers, including hospitals,
cancer centers, physicians, primary care providers, and
specialty providers, to which the provisions of this section
shall apply.
''(2) Definition.--For purposes of this section, the term
'specified health care provider' means a provider of services
or supplier specified under paragraph (1).
''(c) Identification and Endorsement of Breast Cancer Treatment
Performance Measures.--
''(1) In general.--Under the system, the Secretary, shall
enter into agreements with the National Quality Forum, an
organization that operates as a voluntary consensus standards
body as defined for purposes of section 12(d) of the National
Technology Transfer and Advancement Act of 1995 (Public Law
104-113) and Office of Management and Budget Revised Circular
A-119 (published in the Federal Register on February 10, 1998),
under which the National Quality Forum shall identify a uniform
set of consensus-based performance measures to evaluate the
quality of care provided by specified health care providers for
the treatment of breast cancer, endorse such set of measures
through its multistakeholder consensus development process, and
annually update such set of measures.
''(2) Measures described.--The set of measures described in
paragraph (1) shall include, with respect to the treatment of
breast cancer, measures of patient outcomes, the process for
delivering medical care related to such treatment, patient
counseling and engagement in decision-making, patient
experience of care, resource use, and practice capabilities,
such as care coordination.
''(d) Reporting Process.--
''(1) In general.--Under the system, for periods (as
specified by the Secretary) beginning on or after October 1,
2009, the Secretary shall establish a reporting process, with
respect to treatment furnished for breast cancer, that provides
for a method for specified health care providers to submit to
the Secretary data on the performance of such providers during
each period through use of the performance measures developed
pursuant to subsection (c)(1). Such data shall be submitted in
a form and manner and at a time specified by the Secretary.
''(2) Voluntary submission during initial 3 years.--The
reporting process under paragraph (1) shall provide for the
voluntary submission of data (and incentives for such
submission) under the process for periods ending before October
1, 2012.
''(3) Characteristics of data submitted under reporting
process.--Data submitted by a specified health care provider
under the reporting process under paragraph (1) shall--
''(A) take into account the quality of breast
cancer treatment furnished to all patients of the
provider, regardless of the type of health insurance
coverage of the patient or whether or not the patient
has such coverage; and
''(B) be structured in a manner that allows for
comparison according to race, educational level,
income, insurance status, and any other category
specified by the Secretary.
''(e) Public Disclosure.--Under the system, the Secretary shall
establish procedures to require that information with respect to the
quality demonstrated by a specified health care provider of treatment
furnished for breast cancer during a period (based on the performance
measures data submitted pursuant to subsection (c)(1) by the provider
for such period) is made available on the official public Internet site
of the Department of Health and Human Services in a clear and
understandable form. Such procedures shall ensure that a specified
health care provider has the opportunity to review the information that
is to be made public with respect to the provider at least 30 days
prior to such data being made public and shall provide for an appeals
process in the case a provider claims such information to be incorrect
or incomplete.
''(f) Value-Based Purchasing for Periods Beginning October 1,
2012.--
''(1) In general.--Under the system, for periods beginning
on or after October 1, 2012 and ending before October 1, 2015,
the Secretary shall establish and implement, a value-based
purchasing program, with respect to specified health care
providers that furnish treatment for breast cancer during such
a period, under which--
''(A) in the case of such a provider that does not
submit data in accordance with the reporting process
under subsection (d)(1) for such treatment furnished
during such period, the Secretary shall reduce payment
under this title for such treatment by an amount
specified by the Secretary; and
''(B) in the case of such a provider that submits
data in accordance with the reporting process under
subsection (d)(1) for such treatment furnished during
such period--
''(i) subject to clause (ii), if the
Secretary determines such provider furnished
low quality care (in accordance with a method
specified by the Secretary) for such treatment,
the Secretary shall reduce the amount that
would otherwise be paid to such provider under
this title for such treatment by an amount
specified by the Secretary;
''(ii) if the Secretary determines such
provider furnished low quality care (in
accordance with the method specified under
clause (i)) for such treatment, but the quality
of care has improved as compared to the quality
of care the provider furnished during the
previous period, the Secretary shall reduce the
amount that would otherwise be paid to such
provider under this title for such treatment in
accordance with an incremental method
established by the Secretary that ensures that
the amount of such reduction--
''(I) is less than the amount
specified by the Secretary under clause
(i); and
''(II) is based on the extent of
improvement in the quality of care; and
''(iii) if the Secretary determines such
provider did not furnish low quality care (in
accordance with the method specified under
clause (i)) for such treatment, the Secretary
shall provide to such provider the amount to be
paid to such provider under this title for such
treatment.
''(2) Results-based payments.--The amount of a reduction
under subparagraph (A) or (B)(i) of paragraph (1) shall be
determined in accordance with a method established by the
Secretary.
''(g) Reports.--Not later than October 1, 2010, and for each 6-
month period thereafter (before fiscal year 2016), the Secretary shall
submit to Congress a report that evaluates the development and
implementation of the system, including--
''(1) an evaluation of the number of specified health care
providers that submit data pursuant to subsection (c)(1);
''(2) an analysis of the effect of such system on reducing
disparities in the provision of breast cancer treatment to
patients based on race, level of education, income, and health
insurance status of such patients;
''(3) recommendations on whether (and to what extent) to
extend the system under this section.
''(h) Application to Part C.--The Secretary shall provide for a
method to apply the provisions of this section to treatment furnished
under a plan under part C.''.

Ex Output:
Eliminating Disparities in Breast Cancer Treatment Act of 2008 - Amends title XVIII (Medicare) of the Social Security Act to direct the Secretary of Health and Human Services to establish a breast cancer treatment quality performance system to: (1) assess and disclose publicly, through the use of quality measures, the quality of care provided for the treatment of breast cancer by specified health care providers; and (2) base payment to such providers for such treatment on their performance with respect to such measures.

Requires reduced payments to providers that either do not submit data in accordance with the reporting process in the system, or furnish low quality care for treatment of breast cancer.